As of August 28, 2026, Protagonist Therapeutics, Inc. (PTGX) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. Protagonist Therapeutics, Inc. has a market capitalization of $6.40B, 64.71M shares outstanding, 325 institutional holders tracked. Stored dilution-related fields include 1.50M outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PTGX.
Market Data
Market Cap$6.40B
Shares Outstanding64.71M
Float52.49M
Cash$782.58M
Debt$9.83M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 18.2% shares (2026Q1 vs prior)
325 institutional holders · 94.72M shares
#1
BlackRock, Inc.
9.78M shares
#2
JOHNSON & JOHNSON
7.35M shares
#3
FARALLON CAPITAL MANAGEMENT LLC
6.35M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest7.54M
Days to Cover14.2
% of Float14.4%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2016-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual PTGX Dilution Snapshot
Protagonist Therapeutics, Inc. (PTGX) has a DilutionScore of 11/100, rated Low dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 1.5M.
- Recent SEC activity tracked for PTGX: xbrl on 2026-06-30; xbrl on 2016-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track PTGX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTGX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for PTGX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.